Article detail · 2020
Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib
ISSN1078-1552
YÖKSİS
OpenAlex
Data source split
- YÖKSİSYÖKSİS article record
- YÖKSİS venueJournal of Oncology Pharmacy Practice
- Catalog match (ISSN)Journal of Oncology Pharmacy Practice
- OpenAlexOpenAlex enrichment (abstract, citations, topics)
- Semantic Scholarcitation count (not merged with OpenAlex)
Abstract
Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.